The results may be most applicable to women with adenomyosis who wish to preserve fertility, present with moderate-to-severe symptoms, or have larger uterine volumes and elevated CA-125 levels, in whom longer treatment durations may yield more pronounced benefits. Here, MUC16 is linked to adenomyosis.